RFTN2: A Protein with Potential for Drug Targeting (G130132)

Target Name: RFTN2

NCBI ID: G130132

RFTN2

RFTN2: A Protein with Potential for Drug Targeting

Raft-linking protein 2 (RFTN2) is a protein that plays a crucial role in the regulation of cell division and growth in various organisms, including humans. RFTN2 is a member of the F-actinin family, which is known for its ability to form bonds with actinin filaments. RFTN2 is expressed in various tissues and cells of the body and is involved in various cellular processes, including cell adhesion, migration, and cytoskeletal organization.

The Importance of RFTN2

RFTN2 is one of the key proteins that help maintain the integrity of the cytoskeleton and cell organization. It plays a critical role in the regulation of cell division and growth by helping to maintain the proper structure of the actinin network. RFTN2 helps to ensure that actinin filaments are properly organized and that cells remain adhered to the surrounding matrix.

In addition to its role in cytoskeletal organization, RFTN2 is also involved in the regulation of cell adhesion and migration. It helps to promote the stickiness of cells to the surrounding matrix, which is essential for the proper functioning of tissues and organs. RFTN2 is also involved in the regulation of cell cycle progression, as well as in the regulation of cell survival and apoptosis.

Drug Targeting and Biomarker

Due to its involvement in various cellular processes, RFTN2 has been identified as a potential drug target. Researchers are currently working to develop small molecules that can inhibit the activity of RFTN2 and enhance its protein levels to treat various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the most promising small molecules that may target RFTN2 is a drug called NEDD8, which is a non-coding RNA molecule that can interact with RFTN2. NEDD8 has been shown to play a critical role in the regulation of cellular processes, including cell division, growth, and apoptosis.

In preclinical studies, NEDD8 has been shown to inhibit the activity of RFTN2 and enhance the levels of RFTN2 in various cell types. This suggests that NEDD8 may be an effective drug target for the treatment of diseases that are characterized by the over-expression of RFTN2.

Another potential biomarker for RFTN2 is its ability to form bonds with actinin filaments. This property makes RFTN2 an ideal candidate for the development of a drug that can block the activity of RFTN2 and disrupt the actinin network.

Conclusion

Raft-linking protein 2 (RFTN2) is a protein that plays a critical role in the regulation of cell division and growth in various organisms. Its role in these processes makes RFTN2 an attractive target for the development of drugs that can treat various diseases. The identification of NEDD8 as a potential drug target for RFTN2 adds to the growing list of promising small molecules that may be used to treat a variety of diseases. Further research is needed to determine the full potential of RFTN2 as a drug target and to develop effective treatments for the various diseases that are characterized by the over-expression of this protein.

Protein Name: Raftlin Family Member 2

Functions: Upon bacterial lipopolysaccharide stimulation, mediates clathrin-dependent internalization of TLR4 in dendritic cells, resulting in activation of TICAM1-mediated signaling and subsequent IFNB1 production. May regulate B-cell antigen receptor-mediated signaling

The "RFTN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RFTN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets